• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    s00330-017-4972-z.pdf
    Size:
    1.827Mb
    Format:
    PDF
    Description:
    Full text, Open Access article
    Download
    Authors
    deSouza, N
    Winfield, J
    Waterton, John C
    Weller, A
    Papoutsaki, M-V
    Doran, S
    Collins, D
    Fournier, L
    Sullivan, D
    Chenevert, T
    Jackson, Alan
    Boss, M
    Trattnig, S
    Liu, Y
    Show allShow less
    Affiliation
    CRUK Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Downs Road, Surrey, SM2 5PT, UK. Nandita.Desouza@icr.ac.ukCRUK Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Downs Road, Surrey, SM2 5PT, UKManchester Academic Health Sciences Institute, University of Manchester, Manchester, UKCRUK Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Downs Road, Surrey, SM2 5PT, UKCRUK Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Downs Road, Surrey, SM2 5PT, UKCRUK Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Downs Road, Surrey, SM2 5PT, UKCRUK Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Downs Road, Surrey, SM2 5PT, UKAssistance Publique-Hopitaux de Paris, Hopital Europeen Georges Pompidou, Radiology Department, Universite Paris Descartes Sorbonne Paris Cite, Paris, FranceDuke Comprehensive Cancer Institute, Durham, NC, USADepartment of Radiology, University of Michigan Health System, Ann Arbor, MI, USAManchester Academic Health Sciences Institute, University of Manchester, Manchester, UKApplied Physics Division, National Institute of Standards and Technology (NIST), Boulder, CO, USADepartment of Biomedical Imaging and Image guided Therapy, Medical University of Vienna, 1090, Vienna, AustriaEuropean Organisation for Research and Treatment of Cancer, Headquarters, Brussels, Belgium
    Issue Date
    2017-09-27
    
    Metadata
    Show full item record
    Abstract
    For body imaging, diffusion-weighted MRI may be used for tumour detection, staging, prognostic information, assessing response and follow-up. Disease detection and staging involve qualitative, subjective assessment of images, whereas for prognosis, progression or response, quantitative evaluation of the apparent diffusion coefficient (ADC) is required. Validation and qualification of ADC in multicentre trials involves examination of i) technical performance to determine biomarker bias and reproducibility and ii) biological performance to interrogate a specific aspect of biology or to forecast outcome. Unfortunately, the variety of acquisition and analysis methodologies employed at different centres make ADC values non-comparable between them. This invalidates implementation in multicentre trials and limits utility of ADC as a biomarker. This article reviews the factors contributing to ADC variability in terms of data acquisition and analysis. Hardware and software considerations are discussed when implementing standardised protocols across multi-vendor platforms together with methods for quality assurance and quality control. Processes of data collection, archiving, curation, analysis, central reading and handling incidental findings are considered in the conduct of multicentre trials. Data protection and good clinical practice are essential prerequisites. Developing international consensus of procedures is critical to successful validation if ADC is to become a useful biomarker in oncology.
    Citation
    Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives. 2017, Eur Radiol
    Journal
    European Radiology
    URI
    http://hdl.handle.net/10541/620605
    DOI
    10.1007/s00330-017-4972-z
    PubMed ID
    28956113
    Type
    Article
    Language
    en
    ISSN
    1432-1084
    ae974a485f413a2113503eed53cd6c53
    10.1007/s00330-017-4972-z
    Scopus Count
    Collections
    All Paterson Institute for Cancer Research

    entitlement

    Related articles

    • Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging.
    • Authors: Giannotti E, Waugh S, Priba L, Davis Z, Crowe E, Vinnicombe S
    • Issue date: 2015 Sep
    • Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.
    • Authors: Newitt DC, Zhang Z, Gibbs JE, Partridge SC, Chenevert TL, Rosen MA, Bolan PJ, Marques HS, Aliu S, Li W, Cimino L, Joe BN, Umphrey H, Ojeda-Fournier H, Dogan B, Oh K, Abe H, Drukteinis J, Esserman LJ, Hylton NM, ACRIN Trial Team and I-SPY 2 TRIAL Investigators
    • Issue date: 2019 Jun
    • Repeatability and reproducibility of ADC measurements: a prospective multicenter whole-body-MRI study.
    • Authors: Michoux NF, Ceranka JW, Vandemeulebroucke J, Peeters F, Lu P, Absil J, Triqueneaux P, Liu Y, Collette L, Willekens I, Brussaard C, Debeir O, Hahn S, Raeymaekers H, de Mey J, Metens T, Lecouvet FE
    • Issue date: 2021 Jul
    • Technical Note: A safe, cheap, and easy-to-use isotropic diffusion MRI phantom for clinical and multicenter studies.
    • Authors: Pullens P, Bladt P, Sijbers J, Maas AI, Parizel PM
    • Issue date: 2017 Mar
    • Quantification and reduction of cross-vendor variation in multicenter DWI MR imaging: results of the Cancer Core Europe imaging task force.
    • Authors: Sedlaczek OL, Kleesiek J, Gallagher FA, Murray J, Prinz S, Perez-Lopez R, Sala E, Caramella C, Diffetock S, Lassau N, Priest AN, Suzuki C, Vargas R, Giandini T, Vaiani M, Messina A, Blomqvist LK, Beets-Tan RGH, Oberrauch P, Schlemmer HP, Bach M, CCE – Imaging Task Force
    • Issue date: 2022 Dec
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.